Portal de Periódicos da CAPES

Vaccination of patients with liver disease: Who, when, and how

1998; Wiley; Volume: 4; Issue: 2 Linguagem: Inglês

10.1002/lt.500040213

2331-3293

David H. Van Thiel,

Viral gastroenteritis research and epidemiology

Liver Transplantation and SurgeryVolume 4, Issue 2 p. 185-187 EditorialFree Access Vaccination of patients with liver disease: Who, when, and how D.H. Van Thiel, MD, Corresponding Author D.H. Van Thiel, MD Division of Gastroenterology, Department of Medicine, Loyola University Medical Center, Maywood, IL2160 South First Avenue, Building 114, Room 54, Maywood, IL 60153Search for more papers by this author D.H. Van Thiel, MD, Corresponding Author D.H. Van Thiel, MD Division of Gastroenterology, Department of Medicine, Loyola University Medical Center, Maywood, IL2160 South First Avenue, Building 114, Room 54, Maywood, IL 60153Search for more papers by this author First published: 30 December 2003 https://doi.org/10.1002/lt.500040213Citations: 19AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 1994; 23: 437– 455.MEDLINE 2 Seeff L, Koff RS. Evolving concepts of the clinical and serologic consequence of hepatitis B virus infection. Semin Liver Dis 1986; 6: 11– 22.MEDLINE 3 Stremmel W, Schwarzendrube J, Nederau C, Strohmeyer G. Epidermology, clinical course, and treatment of chronic viral hepatitis. Hepatogastroenterology 1991; 31: 21– 24. 4 Hoofnagle JH, Seeff LB, Bales ZB, Zimmerman HJ. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antibody. N Engl J Med 1978; 298: 1379.MEDLINE 5 Douglas DD, Rakela J, Mamish D, Wright TL, Krom RAF, Weisner RH. Transmission of hepatitis B virus (HBV) infection from orthotopic donor livers. Hepatology 1992; 16: 49a. 6 Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, et al. The risk of transmission of hepatitis B from HBsAg negative, HBcAb positive, HBIgM negative organ donors. Transplantation 1995; 59: 230– 234.MEDLINE 7 Samuel D, Alexander G. Liver transplantation for hepatitis B virus infection. Liver Transpl Surg 1995; 1: 270– 274.MEDLINE 8 Todo S, Demetris AJ, Van Thiel DH, Tepperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation in patients with hepatitis B virus related liver disease. Hepatology 1991; 13: 619– 626.MEDLINE 9 Chalasani N, Smallwood G, Halcomb J, Fried MW, Boyer TD. Is vaccination against hepatitis B infection indicated in patients waiting for or following orthotopic liver transplantation? Liver Transpl Surg 128– 132 .MEDLINE 9a Hadler SC, Francis DP, Maynard JE, Thompson SE, Judson FN, Echenberg DF, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual males. N Engl J Med 1986; 315: 209– 214.MEDLINE 10 Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokinet 1992; 22: 434– 446.MEDLINE 11 Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W. Hepatitis B vaccine in patients receiving hemodialysis: Immunogenicity and efficacy. the Dialysis Vaccine Trial Study Group. N Engl J Med 1984; 311: 496– 501.MEDLINE 12 Crosnier J, Junger P, Courouce AM, Laplanche A, Benhamou E, Degos F, et al. Randomized placebo controlled trial of hepatitis B surface antigen vaccine in French hemodialysis units: II. Hemodialysis patients. Lancet 1981; 1: 797– 800.MEDLINE 13 Van Thiel DH, El-Ashmawy L, Love K, Gavaler JS, Starzl TE. Response to hepatitis B vaccination by liver transplant candidates. Dig Dis Sci 1992; 37: 1245– 1249.MEDLINE 14 Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the immunization practices advisory committee (ACIP). RR-13 MMWR 1991; 40: 1– 19. 15 Measles—United States, 1996 and the interruption of indigenous transmission. MMWR 1997; 46: 242– 246. 16 Noker DJ, Swinton J. Vaccination in pulses: A strategy for global eradication of measles and polio. Trends in Microbiology 1997; 5: 14– 19.MEDLINE 17 de Quadros CA, Hersh BS, Olive JM, Andras JK, da Silveira CM, Carrasco PA. Eradication of wild polio virus from the Americas: Acute flaccid paralysis surveillance 1988–1995. J Infect Dis 1997; 175(suppl 1) :537– 542. Citing Literature Volume4, Issue2March 1998Pages 185-187 ReferencesRelatedInformation